Weight Loss Medication
Unsuccessful Weight Loss is Frustrating, Confusing and Devastating
Most People Succeed Initially and Then Experience Weight Regain AGAIN
AND YES, Many Need Medication or Surgery to Reach their Weight Loss Goals
THAT IS OK! Let our Interdisciplinary Team Support You with this Journey
The New
Generic Name: Liraglutide
FDA Approval Year: 2014
BMI Criteria (Obesity): ≥30 kg/m2
Rx Required: Yes
The Good:
- Helps you end meals earlier
- Helps keep you full longer
- Weight Loss @1-year = 6%
- Treatment for Type 2 Diabetes
- Good side effect profile
The Bad
- Nausea is common when starting
- Once a day injection
- Expensive, may be a high co-payment
- Not all insurances cover it
- Usually needs MD supervision, detailed diet, exercise and behavior counseling
Generic Name: Semaglutide
FDA Approval Year: 2021
BMI Criteria (Obesity): ≥30 kg/m2
Rx Required: Yes
The Good:
- Best in class for weight loss
- Helps you end meals earlier
- Help keeps you full longer
- Weight Loss @1-year = 15%
The Bad
- Nausea is common when starting
- Expensive, may be a high co-payment
- Not all insurances cover it (usually needs MD supervision, detailed diet, exercise and behavior counseling)
The Old
Generic Name: Diethylpropion
FDA Approval Year: 1959
BMI Criteria (Obesity): ≥30 kg/m2
Rx Required: Yes
The Good:
- Suppresses Appetite
- Many Doses Available
- Cheap
The Bad
- May develop tolerance and regain weight
- Can increase blood pressure & heart rate
- Not safe for use in some people (Ask MD)
Generic Name:
FDA Approval Year: 1973
BMI Criteria (Obesity): ≥30 kg/m2
Rx Required: Yes
The Good:
- Suppresses Appetite
- Many Doses Available
- Cheap
The Bad
- May develop tolerance and regain weight
- Can increase blood pressure & heart rate
- Not safe for use in some people (Ask MD)
Generic Name: Orlistat
FDA Approval Year: 1999
BMI Criteria (Obesity): ≥30 kg/m2
Rx Required: Rx Dose = 120 mg | OTC Dose = 60 mg
The Good:
- Reduces Fat Absorption
- Weight Loss @ 1-year = 4%
The Bad
- May develop tolerance and regain weight
- GI side effects can be significant
- Weight Loss at 4-years is 2.6%
Generic Name: + Topiramate
FDA Approval Year: 2012
BMI Criteria (Obesity): ≥30 kg/m2
Rx Required: Yes
The Good:
- Suppresses Appetite
- Combination Therapy
- Weight Loss @1-year = 6-9%
The Bad
- Side Effect: Concentration difficulties
- Side Effect: Memory loss
- Weight Loss @2-year = 7-9%
Generic Name: Bupropion + Naltrexone
FDA Approval Year: 2012
BMI Criteria (Obesity): ≥30 kg/m2
Rx Required: Yes
The Good:
- Suppresses Appetite
- Combination Therapy
- Weight Loss @1-year = 4%
The Bad
- Must not be on Opiates
- Not safe for use in some people (Ask MD)
- No Weight Loss Study >1-year = ???